Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Q.E.P. CO., INC. Declares Regular Quarterly Cash Dividend
-
Fusemachines Launches fuse.ai to Showcase the Future of AI Twins in the Workplace
-
Mint Enters into OEM Supply and License Agreement with Ireland-based Centridex to Expand into Europe
-
Hard Rock Stadium Selects Clover Sport to Power Point-of-Sale Solutions
-
Alliance Entertainment Announces October 2026 Investor Conference Schedule
-
BioNexus to Build AI Applications for Malaysian Healthcare Under Exclusive CogniAI Licence
-
Cyllene Therapeutics Presents Interim Data from Phase 1b/2a Clinical Trial Showing EG110A Reduced Urinary Episodes in Patients with Spinal Cord Injury at the International Continence Society (ICS) Con
-
Propanc Biopharma Reports Data Showing 90% Tumor Growth Inhibition with PRP in Pancreatic Cancer Models, Contrasting Profile with Revolution Medicines’ Daraxonrasib
-
Dave’s Hot Chicken Gives Everyone a Free Slider on Dave’s Day; October 13 Marks the Fourth Annual Giveaway
-
Theialife Announces Positive Type C Meeting with FDA for ND10 in Progressive Myopia
-
RenovoRx Advances TAMP™ into Borderline Resectable Pancreatic Cancer with First Patient Enrolled in Investigator-Initiated PRISM-TAMP Trial
-
OneMedNet Signs Mediplexus as its 11th Channel Partner, Expanding the Company’s Real World Data Footprint into Korea and the Asia Pacific Region
-
AVAX One Announces Significant Balance Sheet Progress In Third Quarter 2026
-
Ultragenyx Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $210 Million
-
SEMA4D Blockade Reshapes the Tumor Immune Environment in Neoadjuvant Melanoma Study
-
DeFi Development Corp. to Participate in the 2026 Maxim Growth Summit
-
Beeline to Host Stakeholder Update Call on Q3 2026 Financial Results
-
Notification under Chapter 9, Section 10 of the Securities Market Act: Holdings of Töysän Säästöpankkisäätiö in Oma Savings Bank Plc has fallen below the flagging threshold
-
Notification under Chapter 9, Section 10 of the Securities Market Act: Holdings of Kuortaneen Säästöpankkisäätiö in Oma Savings Bank Plc has fallen below the flagging threshold
-
Apryse Expands Document SDKs to Reduce Custom Development Across AI, Editing and Capture Workflows
-
Progyny, Inc. Selling Season Pacing to Record Level, Revealing Critical Insights on Latest Market Dynamics
-
SciSparc: Subsidiary NeuroThera Labs’ CliniQuantum Reports Successful Quantum-Enabled Analysis of Billions of Gene Combinations Using Real-World Clinical Data on an S&P 500 Company’s Quantum A
-
SciSparc: Subsidiary NeuroThera Labs’ CliniQuantum Reports Successful Quantum-Enabled Analysis of Billions of Gene Combinations Using Real-World Clinical Data on an S&P 500 Company’s Quantum Archi
-
Guelph psychotherapist preparing to ask Queen’s Park for OHIP coverage of psychotherapy
-
American Service Partners Launches National Home Services Platform, Acquiring Brands From Platform Partner Holdings and Exuma Capital
-
FDA Grants SeaStar Medical Breakthrough Device Designation for its SCD Therapy for the Treatment of Hyperinflammation in Adult Patients with Sepsis or a Septic Condition
-
FuelCell Energy Announces Chief Financial Officer Transition
-
MAIA Biotechnology Achieves Patient Enrollment Milestones in Ongoing Phase 2 and Pivotal Phase 3 Clinical Trials in Non-Small Cell Lung Cancer
-
BookingCentral Launches AI Connector, Letting Rental and Tour Operators Ask Claude or ChatGPT About Their Fleet, Bookings and Customers in Plain English
-
VivoSim Labs Celebrates Updated FDA Regulations Allowing Greater use of Non-Animal Testing Methods
-
Byondis to Profile Potential of Platform Technologies at World ADC San Diego, Advancing Strategy to Lead the Antibody-Drug Conjugate Field
-
EXL schedules third quarter 2026 financial results conference call
-
Safe Pro Expects Record 2,300% Revenue Growth in Q3 2026 Driven by Multiple Government Contracts for AI-Powered Threat Detection and Mapping
-
Skyworks Si829x Isolated Safety Gate Driver Qualified and Ready for Customer Evaluation
-
Cerevance Announces Positive Phase 3 ARISE Results: Once-daily Oral Solengepras Meets Primary Endpoint and Demonstrates Motor and Non-motor Benefits in Parkinson's Disease
-
AltruBio to Present Data from ALTB-268 Phase 2a Trial on Ulcerative Colitis at United European Gastroenterology (UEG) Week 2026
-
Jasper Therapeutics Announces Commencement of an Offer to Purchase Outstanding Warrants
-
American Fusion Restructures Up to $2.88 Million of Stock-Based Compensation Obligations into Long-Term, Lock-Up Preferred Equity and Begins Auditor Transition to MBP Global LLP
-
SEON Appoints Ken Talanian as Chief Financial Officer
-
Magnum York and C-Era Tee Up to Support Families in Crisis Through Associa Cares Canada
-
Akebia Therapeutics to Conduct Investor Meetings at the Virtual U.S. Bancorp I BTIG Kidney Health Forum
-
Esperion Reaches Settlement Agreement with Sixth ANDA Filer Not to Market Generic Version of NEXLETOL® (bempedoic acid) & NEXLIZET® (bempedoic acid & ezetimibe) Prior to April 19, 2040
-
Melissa Introduces Elected Officials Data for More Effective Government Relations and Advocacy
-
Erin Schaefer, Former Google/YouTube Senior Executive, Joins Roundtable Board to Help Guide Premium-Media OS Growth
-
Cerevance Announces Positive Phase 3 ARISE Results: Once-daily Oral Solengepras Meets Primary Endpoint and Demonstrates Motor and Non-motor Benefits in Parkinson's Disease
-
AMLM Announces Conversion of Worldwide Diversified Holdings, Inc. Note into Common Shares, Strengthening Balance Sheet and Expanding Shareholder Base
-
Healthrise Identifies Key Factors for a Faster, More Efficient EHR Go-Live
-
Atsena Presents Positive Preliminary Safety and Efficacy Results from Parts A and B of the Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis
-
Kaléo Awarded $96.1 Million BARDA Contract to Advance 2-PAM Auto-Injector for U.S. Chemical Threat Preparedness
-
Kyverna Therapeutics to Present Positive Data in Stiff Person Syndrome and Progressive Multiple Sclerosis at MSToronto2026
